bGlucagon-like peptide-1 receptor agonists/b (GLP-1RAs), a class of drugs commonly prescribed for type 2 diabetes, bimprove cardiovascular...

A landmark study in iCurrent Neuropharmacology/i has uncovered a potential link between Glucagon-like bPeptide-1 (GLP-1) receptor agonists-commonly

A landmark study in iCurrent Neuropharmacology/i has uncovered a potential link between Glucagon-like bPeptide-1 (GLP-1) receptor agonists-commonly

Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are managed.

Women demonstrate significantly bhigher awareness and understanding of medlinkobesity drugs/medlink,/b including GLP-1/GIP receptor agonists such

Women demonstrate significantly bhigher awareness and understanding of medlinkobesity drugs/medlink,/b including GLP-1/GIP receptor agonists such

FRIDAY, June 20, 2025 -- People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated...

FRIDAY, June 20, 2025 -- People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated...

MONDAY, June 23, 2025 -- For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like...

bTirzepatide improved kidney function and cardiovascular outcomes/b in patients with bobesity and heart failure/b with preserved ejection fraction